Valiant Laboratories Limited IPO
Valiant Laboratories Limited IPO is listed on BSE and NSE, priced at ₹133–₹140 per share. The stock debuted at ₹162.15, delivering a listing gain of 15.8%. The IPO had a lot size of ₹105 shares and a minimum investment of ₹14,700.
Valiant Laboratories Limited IPO
- IPO Dates
- Sep 27, 2023 – Oct 3, 2023
- Price band
- ₹133-140 per equity share
- Minimum Investment
- ₹14,700
- Issue size
- 11,556,000 shares (aggregating up to ₹152 Cr) #Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr)
- Lot size
- 105
- Allotment Date
- Oct 4, 2023
- Listing
- Oct 6, 2023
- Listing At
- BSE, NSE
IPO timeline
-
Sep 27, 2023
Open Date
Completed
-
Oct 3, 2023
Close Date
Completed
-
Oct 4, 2023
Allotment Date
Completed
-
Oct 6, 2023
Listing Date
Completed
Price Summary
- Last closing
- 79.80 (-43%)
- 52 week high
- 115.46
- 52 week low
- 49.51
- Last update
Valiant Laboratories Limited IPO Essentials
Valiant Laboratories Limited IPO Details
Valiant Laboratories Limited IPO is priced at ₹133-140 per share with a total issue size of 11,556,000 shares (aggregating up to ₹152 Cr) #Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr). The IPO has a lot size of 105 shares and is listed on BSE and NSE.
- Issue price
- ₹133-140 per equity share
- Lot size
- 105 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 11,556,000 shares (aggregating up to ₹152 Cr)
#Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr) - Listing at
- BSE, NSE
- List price
- 162.15(NSE)
- Listing date
- Registrar
- Link Intime India Private Ltd
- Lead manager
-
Unistone Capital Private Limited
Valiant Laboratories Limited IPO Analytics
Valiant Laboratories Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Valiant Laboratories Limited IPO Subscription Status
Valiant Laboratories Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB |
NII
bHNI
sHNI
|
Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 2,178,030 |
1,633,500
1,088,999
544,501
|
3,811,500 | 7,623,030 |
|
Day 1
27-09-23 05:00 PM
|
0.00 x |
0.10x
0.xxx
0.xxx
|
0.62 x | 0.33 x |
|
Day 2
28-09-23 05:00 PM
|
0.05 x |
0.29x
0.xxx
0.xxx
|
1.29 x | 0.72 x |
|
Day 3
29-09-23 05:00 PM
|
1.04 x |
1.52x
6.09x
3.35x
|
3.14 x | 2.19 x |
|
Day 4
03-10-23 05:00 PM
|
20.83 x |
73.63x
78.64x
63.62x
|
16.05 x | 29.75 x |
Valiant Laboratories Limited Valuations
Earnings
- EPS (Post IPO)
- ₹8.91/-
- P/E Ratio
- 15.71
Returns
- RoNW
- 28.86%
Valiant Laboratories Limited Financials( In Crs.)
| 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
|---|---|---|---|
| Assets | 212.76 | 181.81 | 106.31 |
| Revenue | 338.77 | 293.47 | 183.78 |
| Profit After Tax | 29.00 | 27.50 | 30.59 |
Valiant Laboratories Limited Company & Offer Insights
About Valiant Laboratories Limited
Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
Valiant Laboratories Limited Promoter(s)
Shantilal Shivji Vora, Dhanvallabh Ventures LLP (DVL) are the company's promoters of Valiant Laboratories Limited.
Valiant Laboratories Limited IPO Issue Objectives
- •
- Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
- •
- Investment in VASPL for funding its working capital requirements.
- •
- General corporate purposes.
Valiant Laboratories Limited IPO - Anchor Investors
Valiant Laboratories raises Rs 45.74 crore via anchor book ahead of IPO.
Leading Light Fund VCC - The Triumph Fund is the largest investor among four anchor investors, buying 14.81 lakh shares worth Rs 20.73 crore.
Saint Capital Fund and Astorne Captal VCC - Arven together invested Rs 20 crore for 7.14 lakh shares each, while Negen Undiscovered Value Fund is the fourth participant, buying 3.57 lakh shares worth Rs 5 crore.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Valiant Laboratories Limited IPO is a book-built IPO worth ₹11,556,000 shares (aggregating up to ₹152 Cr) #Fresh Issue: 11,556,000 shares (aggregating up to ₹152 Cr). The price band is ₹133–₹140 per share. The IPO opens on Sep 27, 2023 and closes on Oct 3, 2023. It will be listed on BSE and NSE. Link Intime India Private Ltd is the registrar.
The price band of Valiant Laboratories Limited IPO is ₹133 to ₹140 per share.
The lot size of Valiant Laboratories Limited IPO is 105 shares.
The minimum investment for Valiant Laboratories Limited IPO is approximately ₹14,700 based on the upper price band .
Valiant Laboratories Limited IPO opens on Sep 27, 2023 and closes on Oct 3, 2023.
The allotment date of Valiant Laboratories Limited IPO is Oct 4, 2023.
Valiant Laboratories Limited IPO is expected to be listed on Oct 6, 2023, on BSE and NSE .
Valiant Laboratories Limited IPO listed on Oct 6, 2023. It was issued at ₹162.15(NSE) and is currently around ₹79.80 as on 14-May-2026 3:30 PM, which is approximately -43.0% versus issue price. The 52-week high is ₹115.46.
Based on listing and post-listing performance, Valiant Laboratories Limited IPO delivered around -43.0% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.
To buy Valiant Laboratories Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.
Valiant Laboratories Limited IPO valuation snapshot: P/E 15.71, EPS ₹8.91/-, P/B N/A, RoNW 28.86%, and market cap N/A.
To apply for Valiant Laboratories Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Valiant Laboratories Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Valiant Laboratories Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Valiant Laboratories Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Valiant Laboratories Limited IPO allotment status on IPO Ji for quick and easy access.